Gene · 8493
Papers2,396
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,396
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer. | JACC CardioOncol | 2025 | 40841104 | PubTator, text mining | PubMed |
| Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance. | J Ovarian Res | 2025 | 40813689 | PubTator, text mining | PubMed |
Pediatric Embryonal Rhabdomyosarcoma: An Integrated Study of Clinicopathological Features, Pan-cancer Targeted Next-generation Sequencing, and Chromosomal Microarray Analysis from a Single Institution. | Virchows Arch | 2025 | 40810898 | PubTator, text mining | PubMed |
| Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. | Blood Adv | 2025 | 40795227 | PubTator, text mining | PubMed |
| Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma. | Blood Cancer J | 2025 | 40759639 | PubTator, text mining | PubMed |
| Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences. | Hemasphere | 2025 | 40709316 | PubTator, text mining | PubMed |
| Primary extraskeletal osteosarcoma of the esophagus with PPM1D-BCAS3 fusion: a case report and literature review. | Front Med (Lausanne) | 2025 | 40636370 | PubTator, text mining | PubMed |
| Case Report: Novel truncating PPM1D variant in a dichorionic diamniotic (DCDA) twin with Jansen-de Vries syndrome. an updated perspective. | Front Genet | 2025 | 40630121 | PubTator, text mining | PubMed |
| CHIC: A machine learning framework for inferring the presence of high-risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants. | Hemasphere | 2025 | 40620734 | PubTator, text mining | PubMed |
| Association of high-dose radioactive iodine therapy with PPM1D-mutated clonal hematopoiesis in older individuals. | Mol Oncol | 2025 | 40569832 | PubTator, text mining | PubMed |
| WIP1 mutations suppress DNA damage triggered bypass of the mitotic timer. | EMBO J | 2025 | 40551011 | PubTator, text mining | PubMed |
| Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma. | NPJ Precis Oncol | 2025 | 40514379 | PubTator, text mining | PubMed |
| Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women. | Blood | 2025 | 40499013 | PubTator, text mining | PubMed |
| Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms. | Transl Oncol | 2025 | 40494174 | PubTator, text mining | PubMed |
| Molecular dynamics simulations of intrinsically disordered protein regions enable biophysical interpretation of variant effect predictors. | bioRxiv | 2025 | 40462930 | PubTator, text mining | PubMed |
| Targeting NSCLC drug resistance: Systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis. | J R Soc Interface | 2025 | 40425041 | PubTator, text mining | PubMed |
| Identifying prognostic targets in metastatic prostate cancer beyond AR. | FEBS Open Bio | 2025 | 40405591 | PubTator, text mining | PubMed |
| Next-generation sequencing identifies the presence of protein phosphatase 1D, PPM1D, as a potential biomarker of resistance to PARP inhibition in metastatic castration-resistant prostate cancer. | Am J Clin Exp Urol | 2025 | 40400994 | PubTator, text mining | PubMed |
| Gain-of-function PPM1D mutations attenuate ischemic stroke. | Cell Death Differ | 2025 | 40399534 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8493/papers?page=5